ampicillin has been researched along with enoxacin in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (35.71) | 18.7374 |
| 1990's | 4 (28.57) | 18.2507 |
| 2000's | 3 (21.43) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Cui, S; McDermott, PF; Meng, J; Paulsen, I; White, DG; Zhao, S | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Hashida, Y; Konaka, R; Kourai, H; Maseda, H; Shirai, A | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hannan, A | 1 |
| Bruce, AW; Cook, RL; Llano, M; Reid, G | 1 |
| Gough, K; Jephcott, AE | 1 |
| Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
| Bondi, M; Casolari, C; Fabio, U; Galletti, F; Manicardi, G; Messi, P; Neglia, R | 1 |
| Borner, K; Kemmerich, B; Pennington, JE | 1 |
| Bergeron, MG; Boucher, FD; Lavoie, GY | 1 |
| Arman, D; Tural, D; Willke, A | 1 |
| Chen, CH; Chiang, HY; Lee, F; Lee, JH; Lee, SH; Liu, YT; Tsou, TL; Wang, TM | 1 |
| Jiang, X; Qu, K; Sun, X; Wang, J; Wang, X; Xie, G; Xu, Y; Yang, Q; Zhang, X; Zhang, Y; Zhao, J | 1 |
1 trial(s) available for ampicillin and enoxacin
| Article | Year |
|---|---|
Effect on urogenital flora of antibiotic therapy for urinary tract infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Ampicillin; Anti-Infective Agents, Urinary; Enoxacin; Escherichia coli Infections; Female; Humans; Middle Aged; Random Allocation; Urinary Tract Infections; Urogenital System | 1990 |
13 other study(ies) available for ampicillin and enoxacin
| Article | Year |
|---|---|
Contribution of target gene mutations and efflux to decreased susceptibility of Salmonella enterica serovar typhimurium to fluoroquinolones and other antimicrobials.
Topics: Animals; Anti-Infective Agents; DNA Topoisomerases; Drug Resistance, Bacterial; Fluoroquinolones; Gene Targeting; Genes, Bacterial; Mutation; Salmonella Infections, Animal; Salmonella typhimurium | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Mutational upregulation of a resistance-nodulation-cell division-type multidrug efflux pump, SdeAB, upon exposure to a biocide, cetylpyridinium chloride, and antibiotic resistance in Serratia marcescens.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Cetylpyridinium; Disinfectants; Drug Resistance, Multiple, Bacterial; Membrane Proteins; Mutation; Norfloxacin; Quaternary Ammonium Compounds; Serratia marcescens | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Comparative in vitro activity of enoxacin and other fluoroquinolones against multi-resistant strains of Salmonella typhi.
Topics: Ampicillin; Anti-Infective Agents; Chloramphenicol; Drug Resistance, Microbial; Enoxacin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolones; Salmonella typhi; Species Specificity; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 1992 |
In-vitro activity of enoxacin against gonococcal isolates in comparison with that of five other antibiotics.
Topics: 4-Quinolones; Ampicillin; Anti-Bacterial Agents; Cefuroxime; Enoxacin; Humans; Naphthyridines; Neisseria gonorrhoeae; Penicillin G; Penicillinase; Quinolines; Quinolones; Spectinomycin | 1988 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
In vitro antibacterial activity of enoxacin, a new pyridonecarboxylic acid.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Enoxacin; Gentamicins; Humans; Microbial Sensitivity Tests; Naphthyridines | 1987 |
Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Enoxacin; Female; Haemophilus Infections; Haemophilus influenzae; Kinetics; Lung; Male; Mice; Naphthyridines; Ofloxacin; Oxazines; Pneumonia | 1987 |
Comparative bactericidal activity of cefixime, carumonam, enoxacin and roxithromycin with those of other antibiotics against resistant Haemophilus influenzae including beta-lactam tolerant strains.
Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefixime; Cefotaxime; Enoxacin; Haemophilus influenzae; Leucomycins; Microbial Sensitivity Tests; Naphthyridines | 1987 |
In vitro activity of eight antibiotics against Salmonella and Shigella species.
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Enoxacin; Fleroxacin; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Salmonella; Shigella; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Susceptibility of Pseudomonas aeruginosa of various pyocin types to the newly synthesized ampicillin derivative, N-(6,7-difluoroquinolonyl)ampicillin.
Topics: Ampicillin; Ampicillin Resistance; Anti-Infective Agents; Drug Resistance, Microbial; Enoxacin; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Penicillins; Pseudomonas aeruginosa; Pyocins | 1997 |
Affordable automated phenotypic antibiotic susceptibility testing method based on a contactless conductometric sensor.
Topics: Ampicillin; Anti-Bacterial Agents; Conductometry; Costs and Cost Analysis; Enoxacin; Escherichia coli; Kanamycin; Microbial Sensitivity Tests; Sulfadiazine; Thiamphenicol; Vibrio parahaemolyticus | 2020 |